中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
PI3K alpha inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma

文献类型:期刊论文

作者Xie, Qin1,2; Chi, Shuaishuai1,3; Fang, Yanfen1; Sun, Yiming1; Meng, Linghua1; Ding, Jian1,4,5; Chen, Yi1,3
刊名SIGNAL TRANSDUCTION AND TARGETED THERAPY
出版日期2021-03-31
卷号6期号:1页码:3
ISSN号2095-9907
DOI10.1038/s41392-021-00522-6
通讯作者Ding, Jian(jding@simm.ac.cn) ; Chen, Yi(ychen@simm.ac.cn)
资助项目Strategic Priority Research Program of the Chinese Academy of Science[XDA12020101] ; Strategic Priority Research Program of the Chinese Academy of Science[XDA12050101] ; National Natural Science Foundation of China[81521005]
WOS研究方向Biochemistry & Molecular Biology ; Cell Biology
语种英语
出版者SPRINGERNATURE
WOS记录号WOS:000636231100001
源URL[http://119.78.100.183/handle/2S10ELR8/295443]  
专题新药研究国家重点实验室
通讯作者Ding, Jian; Chen, Yi
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, Shanghai, Peoples R China
2.Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou, Peoples R China
3.Univ Chinese Acad Sci, Beijing, Peoples R China
4.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China
5.Shanghai HaiHe Pharmaceut Co Ltd, Shanghai, Peoples R China
推荐引用方式
GB/T 7714
Xie, Qin,Chi, Shuaishuai,Fang, Yanfen,et al. PI3K alpha inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma[J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY,2021,6(1):3.
APA Xie, Qin.,Chi, Shuaishuai.,Fang, Yanfen.,Sun, Yiming.,Meng, Linghua.,...&Chen, Yi.(2021).PI3K alpha inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma.SIGNAL TRANSDUCTION AND TARGETED THERAPY,6(1),3.
MLA Xie, Qin,et al."PI3K alpha inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma".SIGNAL TRANSDUCTION AND TARGETED THERAPY 6.1(2021):3.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。